ICA1 affects APP processing through the PICK1‐PKCα signaling pathway
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14754 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Liangye Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Research Institute Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health an…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Protein Precursor, Cell Cycle Proteins, Protein Kinase C-alpha. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Islet cell autoantigen 1 (ICA1) is involved in autoimmune diseases and may affect synaptic plasticity as a neurotransmitter. Databases related to Alzheimer's disease (AD) have shown decreased ICA1 expression in patients with AD. However, the role of ICA1 in AD remains unclear. Here, we report that ICA1 expression is decreased in the brains of patients with AD and an AD mouse model.
Results
The ICA1 increased the expression of amyloid precursor protein (APP), disintegrin and metalloprotease 10 (ADAM10), and disintegrin and metalloprotease 17 (ADAM17), but did not affect protein half‐life or mRNA levels. Transcriptome sequencing analysis showed that ICA1 regulates the G protein‐coupled receptor signaling pathway. The overexpression of ICA1 increased PKCα protein levels and phosphorylation.
Conclusion
Our results demonstrated that ICA1 shifts APP processing to non‐amyloid pathways by regulating the PICK1‐PKCα signaling pathway. Thus, this study suggests that ICA1 is a novel target for the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Research Institute Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development…
- The Second Affiliated Hospital and Yuying Children's Hospital, Institute of Aging, Key Laboratory of Alzheimer's Disease of Zhejiang Province, Wenzhou Medical University, Wenzhou, China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, China.
ORCID-Profile: Weihui Zhou
Zitieren
APA
Ji, L., Meng, Z., Dong, X., Wang, Q., Jiang, Y., Zhang, J., Hu, D., Guo, S., Zhou, W., & Song, W. (2024). ICA1 affects APP processing through the PICK1‐PKCα signaling pathway. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14754
Vancouver
Ji L, Meng Z, Dong X, Wang Q, Jiang Y, Zhang J, et al. ICA1 affects APP processing through the PICK1‐PKCα signaling pathway. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14754
BibTeX
@article{Ji2024,
author = {Ji, Liangye and Meng, ZiJun and Dong, Xiangjun and Wang, Qunxian and Jiang, Yanshuang and Zhang, Jie and Hu, Dongjie and Guo, Shipeng and Zhou, Weihui and Song, Weihong},
title = {ICA1 affects APP processing through the PICK1‐PKCα signaling pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14754}
}
EUVIMED